Background
atrial fibrillation, ACS
ATRIAL FIBRILLATION, ACUTE CORONARY SYNDROME
About 5%–15% of acute coronary syndrome (ACS) patients undergoing stent implantation have concomitant atrial fibrillation and need both antiplatelet and anticoagulant therapies. The optimal antithrombotic regimen remains uncertain in this scenario.